24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
@Finance
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
ALS
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:20
The World Cup warning: Riots don’t start in the streets. They start online
18:07
“There’s a price where you have to say yes”: CyberArk founder on the $25 billion Palo Alto deal
14:18
"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"
13:32
“There is no better solution for Zim than the one we created”
More stories
Buzz
Most popular
Daily
Weekly
1
"If an engineer in Ireland costs 20% less, it is clearly part of the consideration when deciding where to expand"
2
Iron Dome and Iron Beam maker Rafael unveils new weapon against the drone threat
3
"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"
4
Echo: “Employees have become very good at identifying performative culture”
5
Unicorn Artlist to cut 200 jobs, 40% of workforce, despite surpassing $300 million ARR
More news
ALS
6 stories about ALS
Jon Medved steps down as OurCrowd CEO after ALS diagnosis
21.10.25
|
Meir Orbach
Founder passes the torch to Cali Chill as he moves into Chairman role and focuses on strategic growth.
NeuroSense Therapeutics and NeuraLight collaborate to detect ALS using AI
28.07.22
|
CTech
The collaboration between the Israeli companies will help the scientific community better understand Amyotrophic lateral sclerosis (ALS) and develop effective drugs to treat it
Mind over Matter: The man who turned himself into a cyborg to overcome ALS
13.09.20
|
Yoghev Carmel
After Peter Scott-Morgan was given a year to live, he decided to fight his fate and employed cutting edge technology to stay alive and remain human
ALS Drug Developer NeuroSense Crowdfunds $1.15 Million
05.08.19
|
Adi Pick
The company’s 1,114 new investors will jointly own a 10% stake, the company said
Kadimastem Gets FDA Orphan Drug Designation for ALS Drug
04.11.18
|
Lilach Baumer
The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019
Israeli ALS Treatment Developer Recruits Kite Pharma's CSO as Board Member
05.02.18
|
Dror Reich
Nasdaq-listed BrainStorm develops stem cell therapies for degenerative neurological diseases